✓ Last verified: March 27, 2026 — Edited & verified by Angelica Bottaro for HealingMaps Editorial Staff

Known For: Revive Ketamine (Memphis Ketamine Clinic) in Arlington serves the greater Memphis metro with IV ketamine infusions. Located in Shelby County east of Memphis, the clinic provides ketamine therapy for depression, anxiety, PTSD, and chronic pain to West Tennessee and the Memphis tri-state area.
| Google Reviews | ⭐ Memphis metro / Arlington |
| Location | Arlington, Tennessee |
| Address | 6220 Green Lee Street, STE #2, Arlington, TN 38002 |
| Phone | (901) 317-7900 |
| Website | memphisketamineclinic.com |
| Treatments | IV Ketamine Infusions |
| Conditions Treated | Depression, Anxiety, PTSD, Chronic Pain |
| Cost | Contact clinic for pricing |
| Insurance | Contact clinic for details |
| KAP Available | Not specified |
| Clinical Lead | Contact clinic |
HealingMaps Take: Revive Ketamine brings Memphis-area ketamine therapy to Arlington’s suburban setting. Serves the greater Memphis tri-state area including west TN, north MS, and east AR patients.
Market Position: Revive Ketamine is an IV-ketamine-focused clinic in the Arlington metro — the most common cash-pay protocol in the HealingMaps verified directory.
Industry pricing reference. Revive Ketamine has not published specific per-session pricing — contact the clinic directly for a quote. The calculator above shows typical metro-level cost estimates across protocols, not this clinic’s specific prices.
| Protocol | Typical Industry Cost | Offered Here |
|---|---|---|
| IV Ketamine | $350–$650/session | ✓ Yes |
| Spravato (esketamine) | $0–$250 copay (insured) | — |
| IM Ketamine | $250–$400/injection | — |
| KAP (with therapist) | $400–$1,200/session | — |
| At-home troches | $150–$300/month | — |
Sources: CDC PLACES 2023 (Shelby County, TN, crude prevalence) · U.S. Census ACS 5 Year · HealingMaps proprietary patient inquiry data.
Behind this data: HealingMaps has analyzed 23,496 patient inquiries (Oct 2022 – Mar 2026), mapped 1,473 verified clinics across 3,142 counties, scraped 132 clinic pricing pages, and collected 658 practitioner survey responses. This snapshot reflects our multi-source methodology.
The U.S. ketamine therapy market is $3.4 billion today and projected to reach $6.9 billion by 2030 — more than doubling in a six-year window as access and awareness expand. Source: HealingMaps 2026 Ketamine Clinic Intelligence Report — drawn from 23,496 patient inquiries and 132 clinic website analyses.
This 4-question summary is matched to the protocols and conditions Revive Ketamine treats. Editorial responses are HealingMaps-authored, grounded in our 2026 Ketamine Clinic Intelligence Report.
Revive Ketamine treats depression via IV ketamine (off-label, evidence-based). Insurance coverage is rare for IV/KAP — most patients pay out of pocket. TRD is typically defined as two or more prior antidepressant trials without sufficient response — patients meeting that bar are best candidates here.
Yes — Revive Ketamine treats chronic pain. They use IV ketamine for pain, which typically means longer infusion times and higher cumulative doses than mental-health protocols. Common indications include complex regional pain syndrome (CRPS), fibromyalgia, and certain neuropathic pain syndromes. Pain pricing varies significantly by structure: per-infusion vs. multi-day inpatient packages — verify how this clinic structures their billing.
Yes — Revive Ketamine treats PTSD. Ketamine for trauma differs from depression treatment: dosing is often lower per session, and pairing the protocol with trauma-focused therapy between sessions is common. A reasonable consult question: whether PTSD patients here typically use ketamine alone or alongside an outside therapist.
Yes — Revive Ketamine treats anxiety, including generalized anxiety, social anxiety, and panic disorder. The evidence base for ketamine in anxiety is less robust than for depression, but it can be a meaningful option for patients who haven’t responded to SSRIs or benzodiazepines. Worth asking which of their protocols they typically recommend for anxiety-primary patients.
Leave a Reply